HB4708 establishes a pilot program for long-acting injectable medications for opioid use disorders in Illinois Department of Corrections facilities.
HB4708 mandates the Illinois Department of Corrections to implement a pilot program starting January 1, 2027, to assess the effectiveness of long-acting injectable medications for opioid use disorders for inmates. The program requires these medications to be used in at least one facility, with the Director having the authority to expand it to additional facilities. A minimum of 4,000 administrations must be included in the pilot program.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.